At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> SEC Filings

SEC Filings

  
Filing Description Date Filed Sorted Descending Size View  
SC 13G statement of beneficial ownership May 19, 2008 36.4 KB View HTML View PDF  
10-Q quarterly report May 14, 2008 257.0 KB View HTML View PDF View XLS  
8-K current report May 13, 2008 89.8 KB View HTML View PDF View XLS  
4 dentzer, james e May 5, 2008 24.7 KB View HTML View PDF View XLS  
4 crowley, john f May 5, 2008 39.0 KB View HTML View PDF View XLS  
4 crowley, john f May 5, 2008 43.0 KB View HTML View PDF View XLS  
4 palling, david Apr 28, 2008 25.5 KB View HTML View PDF View XLS  
DEF 14A definitive proxy statement Apr 25, 2008 550.6 KB View HTML View PDF View XLS  
4 patterson, matthew r Apr 16, 2008 28.5 KB View HTML View PDF View XLS  
4 patterson, matthew r Apr 16, 2008 33.6 KB View HTML View PDF View XLS  
4 crowley, john f Apr 4, 2008 38.0 KB View HTML View PDF View XLS  
4 palling, david Apr 3, 2008 26.3 KB View HTML View PDF View XLS  
4 crowley, john f Apr 3, 2008 36.4 KB View HTML View PDF View XLS  
4 dentzer, james e Apr 2, 2008 24.7 KB View HTML View PDF View XLS  
3 gilmore geoffrey Mar 12, 2008 20.9 KB View HTML View PDF View XLS  
4 gilmore, geoffrey Mar 12, 2008 24.8 KB View HTML View PDF View XLS  
4 topper, james n Mar 10, 2008 36.5 KB View HTML View PDF View XLS  
4 topper, james n Mar 10, 2008 42.0 KB View HTML View PDF View XLS  
4 frazier, healthcare iv lp Mar 10, 2008 52.5 KB View HTML View PDF View XLS  
4 frazier, healthcare iv lp Mar 10, 2008 56.7 KB View HTML View PDF View XLS  
Showing 561-580 of 779 Page: 1 ... 25 26 27 28 29 30 31 32 33 ... 39  Previous 20 | Next 20

Copyright © 2014 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy